AbbVie Aims For $1 Billion Sales In Japan By 2020
This article was originally published in PharmAsia News
Executive Summary
Gary M. Winer, the president and CEO of the Japanese subsidiary of the newly formed AbbVie G.K. with headquarters in Tokyo, said in a Mixonline interview the company aims to increase its domestic sales from the current $616 million to $1 billion by 2020.